| 1 |
Shekhar SK. Schizophrenia and COVID-19: A bibliometric analysis of trends and themes. Schizophr Res 2023;254:35-6. [PMID: 36791575 DOI: 10.1016/j.schres.2023.02.013] [Reference Citation Analysis]
|
| 2 |
Percudani M, Panariello A, Deste G, Bassetti R, Borriello G, Cecchetto F, Marco BD, Falini A, Nibbio G, Calzavara-Pinton I, Gulizia D, Lassini A, Lavatelli L, Levi D, Lise F, Malchiodi F, Mosca L, Piccinini G, Radice A, Romagnoni G, Ruzzi F, Turati S, Zanobio A, Vita A. Socio-demographic and clinical characteristics of SARS-CoV-2-positive psychiatric in-patients: A case-control study in the psychiatric wards of a Great Metropolitan Hospital in Milan. Psychiatry Res 2023;322:115042. [PMID: 36736155 DOI: 10.1016/j.psychres.2022.115042] [Reference Citation Analysis]
|
| 3 |
Kaltenboeck A, Portela Millinger F, Stadtmann S, Schmid C, Amering M, Vogl S, Fellinger M. How does the COVID-19 pandemic affect the personal lives and care realities of people with a schizophrenia spectrum disorder? A qualitative interview study. Int J Soc Psychiatry 2023;:207640231156833. [PMID: 36864811 DOI: 10.1177/00207640231156833] [Reference Citation Analysis]
|
| 4 |
Esposito CM, Biagianti B, D'Agostino A, Dell'Osso B, Giordano B, Wiedenmann F, Macellaro M, Serio F, Turtulici N, Gambini O, Brambilla P. First episode psychosis during the Covid-19 pandemic in Milan, Italy: Diagnostic outcomes at 1-year follow-up. Psychiatry Res 2023;321:115068. [PMID: 36724649 DOI: 10.1016/j.psychres.2023.115068] [Reference Citation Analysis]
|
| 5 |
Karanci AN, Ikizer G, Aldemir İD, Bilgehan A, Karagöz C. How did the Covid-19 pandemic affect individuals with schizophrenia from Turkey? Int J Soc Psychiatry 2023;69:277-85. [PMID: 35311388 DOI: 10.1177/00207640221081800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
Bodini L, Bonetto C, Maccagnani A, Bonora A, Polati E, Ricci G, Paolillo C, Amaddeo F, Lasalvia A. Changes in emergency psychiatric consultations in time of COVID-19: a retrospective observational study in the Verona Academic Hospital over the two pandemic years 2020-2021. BMC Emerg Med 2023;23:18. [PMID: 36792989 DOI: 10.1186/s12873-023-00788-9] [Reference Citation Analysis]
|
| 7 |
Helaly AMN, Ghorab DSED. Schizophrenia as metabolic disease. What are the causes? Metab Brain Dis 2023;:1-10. [PMID: 36656396 DOI: 10.1007/s11011-022-01147-6] [Reference Citation Analysis]
|
| 8 |
Rahme C, El Kadri N, Haddad C, Fekih-Romdhane F, Obeid S, Hallit S. Exploring the association between lifetime traumatic experiences and positive psychotic symptoms in a group of long-stay patients with schizophrenia: the mediating effect of depression, anxiety, and distress. BMC Psychiatry 2023;23:29. [PMID: 36635691 DOI: 10.1186/s12888-023-04531-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Barlati S, Nibbio G, Calzavara-Pinton I, Invernizzi E, Cadei L, Lisoni J, Valsecchi P, Deste G, Vita A. Primary and secondary negative symptoms severity and the use of psychiatric care resources in schizophrenia spectrum disorders: A 3-year follow-up longitudinal retrospective study. Schizophr Res 2022;250:31-8. [PMID: 36252294 DOI: 10.1016/j.schres.2022.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Minor KS, Myers EJ, Abel DB, Mickens JL, Ayala A, Warren KK, Vohs JL. Stuck Inside: How Social Functioning in Schizophrenia Changed During the COVID-19 Pandemic. J Nerv Ment Dis 2022;210:915-24. [PMID: 35703234 DOI: 10.1097/NMD.0000000000001558] [Reference Citation Analysis]
|
| 11 |
Forster SE, Gancz NN, Gaither ML, Haas GL, Starver KD, Steinhauer SR. Barriers to Long-acting Injectable Antipsychotic Adherence During the COVID-19 Pandemic: Observations From One Site. J Psychiatr Pract 2022;28:497-504. [PMID: 36355590 DOI: 10.1097/PRA.0000000000000673] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Barlati S, Nibbio G, Bianchi F, Gigli EBL, Calzavara-Pinton I, Cerati C, Fiori J, Lisoni J, Deste G, Vita A. Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting. Psychiatry Res 2022;317:114878. [PMID: 36206591 DOI: 10.1016/j.psychres.2022.114878] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Caldiroli A, Tagliabue I, Turco M, Capuzzi E, Fortunato A, Tringali A, Montana C, Maggioni L, Pellicioli C, Sibilla M, Marcatili M, Crespi G, Colmegna F, Buoli M, Clerici M. Comparing the COVID-19-related PTSD symptoms between psychiatric patients and healthy subjects: an observational retrospective study from Northern Italy. Psychology, Health & Medicine. [DOI: 10.1080/13548506.2022.2121971] [Reference Citation Analysis]
|
| 14 |
Crișan R, Băcilă CI, Morar S. The role of psychological autopsy in investigating a case of atypical suicide in schizophrenia: a case report with a brief review of literature. Egypt J Forensic Sci 2022;12. [DOI: 10.1186/s41935-022-00291-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Schönthaler EMD, Dalkner N, Ratzenhofer M, Fleischmann E, Fellendorf FT, Bengesser SA, Birner A, Maget A, Lenger M, Platzer M, Queissner R, Tmava-berisha A, Berndt C, Martini J, Bauer M, Sperling JD, Vinberg M, Reininghaus EZ. Greater Emotional Distress Due to Social Distancing and Greater Symptom Severity during the COVID-19 Pandemic in Individuals with Bipolar Disorder: A Multicenter Study in Austria, Germany, and Denmark. IJERPH 2022;19:7626. [DOI: 10.3390/ijerph19137626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Tang SW, Leonard BE, Helmeste DM. Long COVID, neuropsychiatric disorders, psychotropics, present and future. Acta Neuropsychiatr 2022;34:109-26. [PMID: 35144718 DOI: 10.1017/neu.2022.6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 17 |
Sánchez-Guarnido AJ, Lucena V, Torrent A, Bosa L, Martinez-López V, Cuartiles-Berenguer A, Batalla I. Mental Health Day Hospitals and Lockdown Due to COVID-19 in Spain. Front Psychol 2022;13:769015. [PMID: 35401338 DOI: 10.3389/fpsyg.2022.769015] [Reference Citation Analysis]
|
| 18 |
Kim SY, Yoo DM, Kwon MJ, Kim JH, Kim JH, Bang WJ, Choi HG. Changes in the Mean of and Variance in Psychological Disease Incidences before and during the COVID-19 Pandemic in the Korean Adult Population. J Pers Med 2022;12. [PMID: 35455692 DOI: 10.3390/jpm12040576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 19 |
Khan U, Habibur Rahman M, Salauddin Khan M, Shahadat Hossain M, Morsaline Billah M. Bioinformatics and Network-based Approaches for Determining Pathways, Signature Molecules, and Drug Substances connected to Genetic Basis of Schizophrenia etiology. Brain Res 2022;:147889. [PMID: 35339428 DOI: 10.1016/j.brainres.2022.147889] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Ainslie M, Brunette MF, Capozzoli M. Treatment Interruptions and Telemedicine Utilization in Serious Mental Illness: Retrospective Longitudinal Claims Analysis. JMIR Ment Health 2022;9:e33092. [PMID: 35311673 DOI: 10.2196/33092] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Li CX, Noreen S, Zhang LX, Saeed M, Wu PF, Ijaz M, Dai DF, Maqbool I, Madni A, Akram F, Naveed M, Li JH. A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies. Biomed Pharmacother 2022;146:112550. [PMID: 34959116 DOI: 10.1016/j.biopha.2021.112550] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 22 |
Caldiroli A, Capuzzi E, Tringali A, Tagliabue I, Turco M, Fortunato A, Sibilla M, Montana C, Maggioni L, Pellicioli C, Marcatili M, Nava R, Crespi G, Colmegna F, Buoli M, Clerici M. The psychopathological impact of the SARS-CoV-2 epidemic on subjects suffering from different mental disorders: An observational retrospective study. Psychiatry Res 2022;307:114334. [PMID: 34902818 DOI: 10.1016/j.psychres.2021.114334] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 23 |
Vita A, Barlati S. The impact of the Covid-19 pandemic on patients with schizophrenia. Eur Neuropsychopharmacol 2022;54:62-4. [PMID: 34462180 DOI: 10.1016/j.euroneuro.2021.08.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 24 |
Vita A, Gaebel W, Mucci A, Sachs G, Erfurth A, Barlati S, Zanca F, Giordano GM, Birkedal Glenthøj L, Nordentoft M, Galderisi S. European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia. Eur Psychiatr 2022;65:e58. [DOI: 10.1192/j.eurpsy.2022.2316] [Reference Citation Analysis]
|
| 25 |
Kotlarska K, Wielgus B, Cichocki Ł. Phenomenology of the COVID-19 Pandemic Experience in Patients Suffering from Chronic Schizophrenia-A Qualitative Analysis. Int J Environ Res Public Health 2021;19:56. [PMID: 35010322 DOI: 10.3390/ijerph19010056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
Caqueo-Urízar A, Urzúa A, Ponce-Correa F, Ferrer R. Psychosocial Effects of the COVID-19 Pandemic on Patients With Schizophrenia and Their Caregivers. Front Psychol 2021;12:729793. [PMID: 34803806 DOI: 10.3389/fpsyg.2021.729793] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 27 |
Kim S. Supporting Patients With Schizophrenia in the Era of COVID-19. Korean J Schizophr Res 2021;24:45-51. [DOI: 10.16946/kjsr.2021.24.2.45] [Reference Citation Analysis]
|
